The fund, under normal circumstances, invests at least 80% of its assets in the securities that comprise the index or investments with economic characteristics similar to the securities included in the index. The index provides exposure to the performance of companies, publicly listed in the United States, Canada and Europe, that are leading the development and application of messenger RNA (“mRNA”) technology. The fund is non-diversified.
Direxion mRNA ETF · Issued by Direxion
No recent news for MSGR. The ingest cron pulls every 15 minutes during market hours.